Sexual risk behaviour of Canadian participants in the first efficacy trial of a preventive HIV-1 vaccine

CMAJ. Canadian Medical Association Journal

Volumn 172, Issue 4, 2005, Pages 479-483

  Lampinen, Thomas M ^a,b   Chan, Keith ^a   Remis, Robert S ^c   Merid, Maraki Fikre ^c   Rusch, Melanie ^a,b   Vincelette, Jean ^d   Logue, Ken ^e   Popovic, Vladimir ^f   Alary, Michel ^g   Schechter, Martin T ^a,b   Hogg, Robert S ^a,b  

^a BRITISH COLUMBIA CENTRE FOR EXCELLENCE IN HIV AIDS   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF MONTREAL   (Canada)

^e TORONTO GENERAL HOSPITAL   (Canada)

^f VaxGen Inc   (United States)

^g LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE; LIVE VACCINE;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFICACY; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; PHASE 3 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SELF REPORT; SEROCONVERSION; SEXUAL BEHAVIOR; SEXUAL INTERCOURSE; VACCINATION;

EID: 20044369553     PISSN: 08203946     EISSN: None     Source Type: Journal    
DOI: 10.1503/cmaj.1031785     Document Type: Article

References (15)

1. Chesney MA, Chambers DB, Kahn JO. Risk behavior for HIV infection in participants in preventive HIV vaccine trials: a cautionary note. J Acquir Immune Defic Syndr Hum Retrovirol 1997;16(4):266-71.
2. Francis DP, Heyward WL, Popovic V, Orozco-Cronin P, Orelind K, Gee C, et al. Candidate HIV/AIDS vaccines: lessons learned from the world's first phase III efficacy trials. AIDS 2003;17(2):147-56.
3. Pollack A, Altman LK. Large trial finds AIDS vaccine fails to stop infection. New York Times 2003 Feb 24;Sect A:1(col 1).
4. Dufour A, Alary M, Otis J, Remis RS, Masse B, Turmel B, et al. Risk behaviours and HIV infection among men having sexual relations with men: baseline characteristics of participants in the Omega Cohort Study, Montreal, Quebec, Canada. Can J Public Health 2000;91(5):345-9.
5. Piaseczna MA, Craib KJ, Li K, Chan K, Weber AE, Strathdee SA, et al. Longitudinal patterns of sexual behavior and condom use in a cohort of HIV-negative gay and bisexual men in Vancouver, British Columbia, Canada, 1995-2000. J Acquir Immune Defic Syndr 2001;28(2):187-93.
6. Calzavara L, Burchell AN, Major C, Remis RS, Corey P, Myers T, et al. Increases in HIV incidence among men who have sex with men undergoing repeat diagnostic HIV testing in Ontario, Canada. AIDS 2002;16(12):1655-61.
7. Lampinen TM, Chan K, Craib KJP, Miller ML, Schilder AJ, Devlin B, et al. Relation between partner HIV-1 status, condom use, and HIV-1 seroincidence among men who have sex with men (MSM) in Vancouver, 2001-2002 [poster presentation]. 12th annual Canadian Conference on HIV/AIDS Research; 2003 Apr 11; Halifax.
8. Wolitski RJ, Valdiserri RO, Denning PH, Levine WC. Are we headed for a resurgence of the HIV epidemic among men who have sex with men? Am J Public Health 2001;91(6):883-8.
9. Buchbinder SP, Douglas JM Jr, McKirnan DJ, Judson FN, Katz MH, MacQueen KM. Feasibility of human immunodeficiency virus vaccine trials in homosexual men in the United States: risk behavior, seroincidence, and willingness to participate. J Infect Dis 1996;174(5):954-61.
10. O'Connell JM, Hogg RS, Chan K, Strathdee SA, McLean N, Martindale SL, et al. Willingness to participate and enroll in a phase 3 preventive HIV-1 vaccine trial. J Acquir Immune Defic Syndr 2002;31(5):521-8.
11. Geduld J, Gatali M, Remis RS, Archibald CP. Estimates of HIV prevalence and incidence in Canada, 2002. Can Commun Dis Rep 2003;29(23):197-207.
12. Dybul M, Fauci AS, Bartlett JG, Kaplan JE, Pau AK. Guidelines for using antiretroviral agents among HIV-infected adults and adolescents. Ann Intern Med 2002;137(5 Pt 2):381-433.
13. Pomerantz RJ. Initiating antiretroviral therapy during HIV infection: confusion and clarity. JAMA 2001;286(20):2597-9.
14. Yeni PG, Hammer SM, Carpenter CC, Cooper DA, Fischl MA, Gatell JM, et al. Antiretroviral treatment for adult HIV infection in 2002: updated recommendations of the International AIDS Society-USA Panel. JAMA 2002;288(2):222-35.
15. Lampinen TM, Baggaley R, Garnett GP, Gataric N, Schechter MT, Montaner JS, et al. Reversion to pre-HAART population levels of viremia concomitant with recent changes in ART prescribing practices [poster abstract TuPeC4722, 15th International AIDS Conference]. Medscape Gen Med [serial online] 2004;6(3). Available: www.iasociety.org/ejias/show.asp?abstract_id= 2175412 (accessed 2005 Jan 12).